Startups
Cytovale
https://cytovale.com/Cytovale is a company that develops biomarkers based on the mechanical properties of cells to identify diseases. It has applied its technology to detect sepsis.
Summary
Total Funding
$119M
- Series D (2024-10-10) $100M
- Series B (2019-10-01) $15.0M
- Series A (2014-06-01) $4.3M
Investors
Norwest Venture Partners Series D
Norwest Venture Partners Series D
CPP Investments Series D
Western Technology Investment Series B
Blackhorn Ventures Series B
Full Company Profile
- Access details of the company management, and other intelligence on this company by registering for Seedtable